Police in China have apprehended the distributor of a deadly diabetes drug that killed two diabetic patients last month. The fake drug contained a lethal dosage of a compound used to lower blood glucose levels .
Police caught the suspected distributor, Li Dong, on Saturday morning at a rented house in Chaoyang city, Liaoning Province, China. Two other associates of the man were also apprehended, and Li has already confessed to bringing in the fake diabetes drugs from another province.
The drug, whose source remains a mystery, has also showed up in Sichuan Province. Thousands of bottles remain at large, with police and health authorities warning diabetics against taking the fake drug.
Suspect held over deadly diabetes drugs
Mon, 09 Feb 2009
Recommended links
Diabetes newsletterDiabetes based financial services
Diabetes guides
Diabetes support forums
New chairman for Diabetes UK
Minority diabetes awareness drive
Side effects of Glaxo drugs
Bristol Myers drugs may raise diabetes risk
Irish diabetes drugs disparity
Strictest health warning on diabetes drugs
Anti-obesity drugs to combat diabetes
Diabetes drugs raise risk of cancer death
Diabetes risk increased by antidepressant drugs
Increased bone risk due to diabetes drugs
Diabetics should use statin drugs more
GlaxoSmithKline short on drugs
Diabetes drugs rights bought by Eli Lilly
Diabetes drugs part of top spend
Bayer and Pfizer pair up on diabetes and obesity drugs
Warnings for diabetes drugs
Europe studies eye problem link to diabetes drugs
Cost of diabetes drugs could soar in next few years
Older drugs perfectly alright for diabetes
Lower risk of diabetes from antipsychotic drugs
Drugs offer diabetes hope
Study to assess drugs in adolescents with diabetes
Blood pressure drugs lower diabetes in Hispanics
ED drugs safe for men with diabetes
U-M free diabetes drugs scheme
Diabetes drugs to be subsidised in Australia
Avandia risk higher than other diabetes drugs
Top ten diabetes drugs compared
Heart risk from two diabetes drugs
Diabetes drugs could help Alzheimers
Meeting on the fate of diabetes drugs





Join us